The B sample of a Malaysian men's badminton player tested positive for banned anti-inflammatory dexamethasone and the player has been temporarily suspended, an official said Saturday.
Badminton Association of Malaysia (BAM) deputy president Norza Zakaria made the announcement following widespread reports naming World No.1 Lee Chong Wei, reports Xinhua.
Lee reportedly flew to Norway to witness the second test this week. But Norza said the player could not be named pending due process, including a hearing of the Badminton World Federation (BWF).
"The result of the testing confirmed the existence of dexamethasone in the sample. We are still not at liberty to reveal the name of the player. I would like to inform you that we believe that this player is a very hard-working player and an exceptional individual," Norza said Saturday.
He confirmed the player in question had denied taking the drug on purpose but received treatment in July for a thigh injury. Lee, 32, received stem cell treatment for a thigh injury in July.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app